Cargando…

Medical Management of Parkinson’s Disease: Focus on Neuroprotection

Neuroprotection refers to the protection of neurons from excitotoxicity, oxidative stress and apoptosis as principal mechanisms of cell loss in a variety of diseases of the central nervous system. Our interest in Parkinson’s disease (PD) treatment is focused on drugs with neuroprotective properties...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boll, Marie-Catherine, Alcaraz-Zubeldia, Mireya, Rios, Camilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131725/ https://www.ncbi.nlm.nih.gov/pubmed/22131943 http://dx.doi.org/10.2174/157015911795596577

Ejemplares similares

The Effect of Supplementation with Omega-3 Polyunsaturated Fatty Acids on Markers of Oxidative Stress in Elderly Exposed to PM(2.5)
por: Romieu, Isabelle, et al.
Publicado: (2008)

Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
por: Marashly, Eyad T., et al.
Publicado: (2017)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
por: Mack, Josiel Mileno, et al.
Publicado: (2016)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

A Hypothesis of the Interaction of the Nitrergic and Serotonergic Systems in Aggressive Behavior Induced by Exposure to Lead
por: Martínez-Lazcano, Juan Carlos, et al.
Publicado: (2018)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotective potential of Beta vulgaris L. in Parkinson's disease
por: Nade, Vandana S., et al.
Publicado: (2015)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
por: Sheng, Xiaoyan, et al.
Publicado: (2021)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

On Disease Modifying and Neuroprotective Treatments for Parkinson's Disease: Physical Exercise
por: Garcia Ruiz, Pedro J., et al.
Publicado: (2022)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models
por: Li, Shichang, et al.
Publicado: (2013)

Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
por: Carrera, Iván, et al.
Publicado: (2019)

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018)

Neuroprotective effect of carnosine against salsolinol-induced Parkinson's disease
por: Zhao, Jun, et al.
Publicado: (2017)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease
por: Zhang, Xi, et al.
Publicado: (2023)

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
por: Di Maio, Roberto, et al.
Publicado: (2023)

Mitochondrial Nutrition as a Strategy for Neuroprotection in Parkinson's Disease—Research Focus in the Department of Alternative Medicine and Experimental Therapeutics at Hokuriku University
por: Mitsumoto, Yasuhide
Publicado: (2007)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
por: Liang, Yan, et al.
Publicado: (2019)

Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson’s disease
por: Yu, Dingyi, et al.
Publicado: (2021)

Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease
por: Kabra, Atul, et al.
Publicado: (2020)

Copper and Copper Proteins in Parkinson's Disease
por: Montes, Sergio, et al.
Publicado: (2014)

Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms
por: Yang, Huajun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n4qevfnl8lsoq84h3hdebe6nln